secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2024-07-26T23:59:59+00:00
Accession:  0001493152-24-029295
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period
--------------------------------------------------------------------------------

- Nasdaq notified PTIX on July 24, 2024 of non-compliance with minimum $1.00 bid price for 30 consecutive business days.
- Company has until January 20, 2025 to regain compliance; requires closing bid of $1.00 for at least 10 consecutive days.
- If not compliant by Jan 20, 2025, PTIX may qualify for an additional 180-day cure period if it meets other listing standards.
- Failure to cure could lead to delisting; the company may appeal any delisting determination to a Nasdaq hearings panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224029295/0001493152-24-029295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224029295/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-029295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer